स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - immunoglobulinum humanum normale - soluzione per infusione per sottocutaneo - i) durchstechflasche mit humanem normalem immunglobulin: immunoglobulinum humanum normale 100 mg, glycinum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. ii) durchstechflasche mit rekombinanter humaner hyaluronidase: hyaluronidasum humanum adnr, dinatrii phosphas, natrii hydroxidum, calcii chloridum anhydricum, natrii chloridum, dinatrii edetas, albumini humani solutio, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 4.03 mg. - substitutionstherapie bei erwachsenen mit primärem immundefektsyndrom mit unzureichender antikörperbildung; substitutionstherapie bei erwachsenen mit sekundären immundefekten (sid). - emoderivati

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - magaldratum - gel - magaldratum 800 mg, acaciae gummi dispersione desiccatum, hypromellosum, maltolum, simeticonum, methylcellulosum, aqua purificata, aromatica, natrii cyclamas, argenti sulfas, chlorhexidini digluconas, e 200, ad gelatum pro dosi 10 ml corresp. natrium 2.42 mg, natrii hypochloris. - antacidum - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - magaldratum - gel - magaldratum 1600 mg, acaciae gummi dispersione desiccatum, hypromellosum, maltolum, simeticonum, methylcellulosum, aqua purificata, aromatica, natrii cyclamas, argenti sulfas, chlorhexidini digluconas, natrii hypochloris, e 200, ad gelatum pro dosi 10 ml corresp. natrium 2.45 mg. - antacidum - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - magaldratum - compresse - magaldratum 800 mg, sorbitolum 718.2-829.3 mg, macrogolum 4000, calcii behenas, maltolum, aromatica, pro compresso. - antacidum - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - fentanylum - depotpflaster - fentanylum 2.75 mg, dipropylenglycolum, excipiens per la preparazione per la 8.4 cm2 con la liberazione di 25 µg/h. - analgesico - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - fentanylum - depotpflaster - fentanylum 5.5 mg, dipropylenglycolum, excipiens per la preparazione per 16,8 cm2 con la liberazione di 50 µg/h. - analgesico - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - fentanylum - depotpflaster - fentanylum 8.25 mg, dipropylenglycolum, excipiens per la preparazione del 25,2 cm2 con rilascio di 75 µg/h. - analgesico - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - fentanylum - depotpflaster - fentanylum 11 mg, dipropylenglycolum, excipiens per la preparazione 33,6 cm2 con la liberazione di 100 µg/h. - analgesico - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - fentanylum - depotpflaster - fentanylum 1.38 mg, dipropylenglycolum, excipiens per la preparazione 4.2 cm2 con la liberazione di 12.5 µg/h. - analgesico - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - hydrocortisonum - compresse a rilascio modificati - hydrocortisonum 5.00 mg, hypromellosum, cellulosum microcristallinum, per amylum pregelificatum, silice colloidalis anhydrica, magnesio stearas, Überzug: macrogolum 3350, poli(alcole vinylicus), talco, e 171, e 172 (giallo) e 172 (rosso) e 172 (nero), per compresso haze. - trattamento della nebennierenrindeninsuffizienz (m. di addison) - synthetika